Tiziana Life Sciences (TLSA) Other Accumulated Expenses (2020 - 2025)

Tiziana Life Sciences' Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $220000.0 for Q2 2025.

• In Q2 2025, Other Accumulated Expenses fell 97.53% year-over-year to $220000.0; the TTM figure through Jun 2025 stood at $220000.0 (down 97.53% YoY), while the FY2023 annual figure was $6.4 million, down 2.22% from the prior year.
• Other Accumulated Expenses for Q2 2025 stood at $220000.0, down from $8.9 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $8.9 million in Q2 2024, with the low at $83000.0 in Q2 2021.
• The 5-year median for Other Accumulated Expenses is $5.3 million (2022), against an average of $4.5 million.
• The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses jumped 6249.4% in 2022, then tumbled 97.53% in 2025.
• Tiziana Life Sciences' Other Accumulated Expenses stood at $83000.0 in 2021, then soared by 7769.88% to $6.5 million in 2022, then declined by 2.22% to $6.4 million in 2023, then jumped by 39.69% to $8.9 million in 2024, then sank by 97.53% to $220000.0 in 2025.
• Business Quant data shows TLSA's Other Accumulated Expenses at $220000.0 in Q2 2025, $8.9 million in Q2 2024, and $6.4 million in Q4 2023.